Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nurse Follow-Up may boost quit rates in COPD smokers

NCT ID NCT05577767

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether regular follow-up calls or visits from a nurse can help smokers aged 35-65 who are screened for COPD to quit smoking. About 233 participants will receive ongoing nursing support. The goal is to see if this simple, low-cost approach reduces the number of cigarettes smoked per day.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nursing follow-up
What this could lead to
If it works, this could show that simple nurse support helps people quit smoking, which may slow COPD progression.
What could go wrong
This is a small, single-center study with no blinding, so results may not apply broadly. Success depends on participants' motivation and follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 233 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2020

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Smoking patients screened for COPD between 35 years old 65 years old

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Smoking patients screened for COPD between 35 years old 65 years old * Read, write and understand the French language * Patient affiliated to a social security system * Written and signed informed consent Exclusion Criteria: * Patients with a diagnosis of respiratory diseases * Patients receiving inhaled respiratory therapy * Persons unable to perform spirometry * Pregnant women * Refusal to participate in research * Patient under guardianship, deprived of liberty, safeguard of justice

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ch Valence

    Valence, Drome, 26953, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.